{"text": ["Novartis", "Beefs", "Up", "Radioligand", "Portfolio", "With", "iTheranostics", "Deal"], "created_at": "2021-03-30 16:51:46"}
{"text": ["Novartis", "(NVS)", "Gets", "EC", "Nod", "For", "Kesimpta", "in", "Relapsing", "Forms", "of", "MS"], "created_at": "2021-03-30 13:57:01"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Wave", "Life", "Sciences", "Pulls", "Plug", "On", "2", "Assets,", "Amarin's", "Vascepa", "Snags", "European", "Approval,", "Biocept", "Jumps", "On", "Earnings"], "created_at": "2021-03-30 12:06:26"}
{"text": ["RPT-UPDATE", "1-Roche,", "Novartis", "approvals", "in", "Europe", "signal", "more", "head-to-head", "competition"], "created_at": "2021-03-30 06:49:24"}
{"text": ["UPDATE", "1-Roche,", "Novartis", "approvals", "in", "Europe", "signal", "more", "head-to-head", "competition"], "created_at": "2021-03-30 06:39:23"}
{"text": ["Novartis", "expands", "targeted", "radioligand", "therapy", "pipeline", "with", "in-license", "for", "compounds", "targeting", "Fibroblast", "Activation", "Protein", "(FAP)"], "created_at": "2021-03-30 05:15:00"}
